Mangalam Drugs & Organics Limited

Equities

MANGALAM

INE584F01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:22:23 2024-05-24 am EDT 5-day change 1st Jan Change
107.4 INR -5.34% Intraday chart for Mangalam Drugs & Organics Limited +6.66% +9.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Mangalam Drugs & Organics Limited Announces Appointment of Shri Rakesh K. Milwani as an Additional Director (Non- Executive Non- Independent Director) CI
Mangalam Drugs & Organics Limited Announces Executive Changes CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Mangalam Drugs & Organics Limited Announces Earnings Results for the First Quarter Ended June 30, 2021 CI
Mangalam Drugs & Organics : and Organics Commissions New Manufacturing Facility in Gujarat, India MT
Mangalam Drugs & Organics Limited Provides Update on Setting-Up of New Intermediate Manufacturing Facility At Unit 1 Located in Vapi, Gujarat CI
Mangalam Drugs & Organics' : Net Profit Plummets in Fiscal Q4; Shares Plunge 8% MT
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Mangalam Drugs & Organics Limited Announces Resignation of Prashant J. Pandit as Independent Director CI
Mangalam Drugs & Organics Limited Announces Resignation of Prashant J. Pandit, Independent Director CI
Mangalam Drugs & Organics Limited Announces Change in Directorate CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2020 CI
Chart Mangalam Drugs & Organics Limited
More charts
Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemicals products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed at research and development) is Bictegravir Na (IH).
More about the company
  1. Stock Market
  2. Equities
  3. MANGALAM Stock
  4. News Mangalam Drugs & Organics Limited
  5. Mangalam Drugs & Organics : and Organics Commissions New Manufacturing Facility in Gujarat, India